99 related articles for article (PubMed ID: 22759791)
1. G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signaling.
Abdulkhalek S; Guo M; Amith SR; Jayanth P; Szewczuk MR
Cell Signal; 2012 Nov; 24(11):2035-42. PubMed ID: 22759791
[TBL] [Abstract][Full Text] [Related]
2. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
Abdulkhalek S; Szewczuk MR
Cell Signal; 2013 Nov; 25(11):2093-105. PubMed ID: 23827939
[TBL] [Abstract][Full Text] [Related]
3. Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling.
Haxho F; Haq S; Szewczuk MR
Cell Signal; 2018 Mar; 43():71-84. PubMed ID: 29277445
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo.
Finlay TM; Abdulkhalek S; Gilmour A; Guzzo C; Jayanth P; Amith SR; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Aug; 27(6):583-600. PubMed ID: 20697956
[TBL] [Abstract][Full Text] [Related]
5. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling.
Abdulkhalek S; Amith SR; Franchuk SL; Jayanth P; Guo M; Finlay T; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
J Biol Chem; 2011 Oct; 286(42):36532-49. PubMed ID: 21873432
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245
[TBL] [Abstract][Full Text] [Related]
7. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling.
Amith SR; Jayanth P; Franchuk S; Finlay T; Seyrantepe V; Beyaert R; Pshezhetsky AV; Szewczuk MR
Cell Signal; 2010 Feb; 22(2):314-24. PubMed ID: 19796680
[TBL] [Abstract][Full Text] [Related]
8. A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes.
Alghamdi F; Guo M; Abdulkhalek S; Crawford N; Amith SR; Szewczuk MR
Cell Signal; 2014 Jun; 26(6):1355-68. PubMed ID: 24583283
[TBL] [Abstract][Full Text] [Related]
9. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
[TBL] [Abstract][Full Text] [Related]
10. Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase.
Amith SR; Jayanth P; Franchuk S; Siddiqui S; Seyrantepe V; Gee K; Basta S; Beyaert R; Pshezhetsky AV; Szewczuk MR
Glycoconj J; 2009 Dec; 26(9):1197-212. PubMed ID: 19430901
[TBL] [Abstract][Full Text] [Related]
11. Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells.
Santiskulvong C; Rozengurt E
Exp Cell Res; 2003 Nov; 290(2):437-46. PubMed ID: 14568001
[TBL] [Abstract][Full Text] [Related]
12. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling.
Jayanth P; Amith SR; Gee K; Szewczuk MR
Cell Signal; 2010 Aug; 22(8):1193-205. PubMed ID: 20347965
[TBL] [Abstract][Full Text] [Related]
13. Detection of Neu1 sialidase activity in regulating Toll-like receptor activation.
Amith SR; Jayanth P; Finlay T; Franchuk S; Gilmour A; Abdulkhalek S; Szewczuk MR
J Vis Exp; 2010 Sep; (43):. PubMed ID: 20864924
[TBL] [Abstract][Full Text] [Related]
14. Functional Selectivity of Cannabinoid Type 1 G Protein-Coupled Receptor Agonists in Transactivating Glycosylated Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition Metastatic Phenotype.
Bunsick DA; Matsukubo J; Aldbai R; Baghaie L; Szewczuk MR
Cells; 2024 Mar; 13(6):. PubMed ID: 38534324
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic Acid Promotes Expression and Activation of Matrix Metalloproteinase 9 (MMP9) in THP-1 Cells via Toll-Like Receptor 4/Nuclear Factor-κB (TLR4/NF-κB) Signaling Pathway.
Zhou ZB; Yang B; Li X; Liu H; Lei G
Med Sci Monit; 2018 Jul; 24():4861-4868. PubMed ID: 30005060
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells.
Salazar EP; Hunger-Glaser I; Rozengurt E
J Cell Physiol; 2003 Mar; 194(3):314-24. PubMed ID: 12548551
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
Gschwind A; Prenzel N; Ullrich A
Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
[TBL] [Abstract][Full Text] [Related]
19. Collagenase-2 and -3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells.
Mukhin YV; Gooz M; Raymond JR; Garnovskaya MN
J Pharmacol Exp Ther; 2006 Sep; 318(3):1033-43. PubMed ID: 16717107
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways.
Bachar O; Adner M; Uddman R; Cardell LO
Eur J Immunol; 2004 Apr; 34(4):1196-207. PubMed ID: 15048731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
